Faculty Articles
Anticoagulation With Dabigatran: When to Worry
Publication Title
Medscape
Publisher
Medscape
Publication Date
9-3-2015
Keywords
anticoagulation, dabigatran, embolism, inhibitor, nonvalvular atrial fibrillation (NVAF) stroke
Abstract
Dabigatran etexilate is the prodrug of dabigatran, a direct thrombin inhibitor that is used to reduce the risk for stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF) and to prevent and treat venous thromboembolism (VTE).
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
NSUWorks Citation
Singh-Franco, Devada, "Anticoagulation With Dabigatran: When to Worry" (2015). Faculty Articles. 371.
https://nsuworks.nova.edu/hpd_corx_facarticles/371